Illumina, Inc. (ILMN)
138.63
-3.95
(-2.77%)
USD |
NASDAQ |
May 07, 16:00
139.12
+0.49
(+0.35%)
After-Hours: 18:13
Illumina Research and Development Expense (Quarterly) : 240.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | -- |
| GeneDx Holdings Corp. | 19.58M |
| Mettler-Toledo International, Inc. | 52.60M |
| Guardant Health, Inc. | 98.26M |
| Waters Corp. | 95.00M |